Exodus Point Capital Management, LP Marker Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.37 - $1.0 $6,946 - $18,775	-18,775 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$0.95 - $1.72 $3,193 - $5,782	-3,362 Reduced 15.19%	18,775 $18,000
Q3 2021 Nov 15, 2021	SELL	$1.68 - $2.88 $36,331 - $62,282	-21,626 Reduced 49.42%	22,137 $37,000
Q2 2021 Aug 16, 2021	BUY	$1.88 - $3.56 $62,013 - $117,430	32,986 Added 306.08%	43,763 $122,000
Q1 2021 May 17, 2021	BUY	$1.47 - $3.29 $15,842 - $35,456	10,777 New	10,777 $24,000
Q2 2019 Aug 14, 2019	SELL	$5.15 - $7.92 $199,541 - $306,868	-38,746 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.1 - $6.71 $65,514 - $86,196	12,846 Added 49.6%	38,746 $256,000
Q4 2018 Feb 14, 2019	BUY	$4.2 - $9.74 $108,780 - $252,266	25,900 New	25,900 $144,000

472K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $234M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.